206 related articles for article (PubMed ID: 23289391)
21. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
22. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
23. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
24. Surface protonation/deprotonation controlled instant affinity switch of nano drug vehicle (NDV) for pH triggered tumor cell targeting.
Wang Z; Ma G; Zhang J; Yuan Z; Wang L; Bernards M; Chen S
Biomaterials; 2015 Sep; 62():116-27. PubMed ID: 26046750
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydrophobicity of core on the anticancer efficiency of micelles as drug delivery carriers.
Sun CY; Ma YC; Cao ZY; Li DD; Fan F; Wang JX; Tao W; Yang XZ
ACS Appl Mater Interfaces; 2014 Dec; 6(24):22709-18. PubMed ID: 25426800
[TBL] [Abstract][Full Text] [Related]
26. Lipid Based Aqueous Core Nanocapsules (ACNs) for Encapsulating Hydrophillic Vinorelbine Bitartrate: Preparation, Optimization, Characterization and In vitro Safety Assessment for Intravenous Administration.
Lakshmi ; Singh S; Vijayakumar MR; Dewangan HK
Curr Drug Deliv; 2018; 15(9):1284-1293. PubMed ID: 30009708
[TBL] [Abstract][Full Text] [Related]
27. Thermally controlled release of anticancer drug from self-assembled γ-substituted amphiphilic poly(ε-caprolactone) micellar nanoparticles.
Cheng Y; Hao J; Lee LA; Biewer MC; Wang Q; Stefan MC
Biomacromolecules; 2012 Jul; 13(7):2163-73. PubMed ID: 22681332
[TBL] [Abstract][Full Text] [Related]
28. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.
Khatun Z; Nurunnabi M; Nafiujjaman M; Reeck GR; Khan HA; Cho KJ; Lee YK
Nanoscale; 2015 Jun; 7(24):10680-9. PubMed ID: 26030737
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
30. Carboxylated poly(glycerol methacrylate)s for doxorubicin delivery.
Ma Y; Gao H; Gu W; Yang YW; Wang Y; Fan Y; Wu G; Ma J
Eur J Pharm Sci; 2012 Jan; 45(1-2):65-72. PubMed ID: 22085680
[TBL] [Abstract][Full Text] [Related]
31. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
32. A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity.
Wu Y; Ihme S; Feuring-Buske M; Kuan SL; Eisele K; Lamla M; Wang Y; Buske C; Weil T
Adv Healthc Mater; 2013 Jun; 2(6):884-94. PubMed ID: 23225538
[TBL] [Abstract][Full Text] [Related]
33. Ultrafine medicated fibers electrospun from W/O emulsions.
Xu X; Yang L; Xu X; Wang X; Chen X; Liang Q; Zeng J; Jing X
J Control Release; 2005 Nov; 108(1):33-42. PubMed ID: 16165243
[TBL] [Abstract][Full Text] [Related]
34. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
35. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Benival DM; Devarajan PV
Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable amphiphilic copolymer containing nucleobase: synthesis, self-assembly in aqueous solutions, and potential use in controlled drug delivery.
Kuang H; Wu S; Xie Z; Meng F; Jing X; Huang Y
Biomacromolecules; 2012 Sep; 13(9):3004-12. PubMed ID: 22889069
[TBL] [Abstract][Full Text] [Related]
37. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
38. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
[TBL] [Abstract][Full Text] [Related]
40. Preparation and evaluation of fast-release mephenamic acid microspheres.
Etman M; Farid R; Nada A; Ebian A
J Microencapsul; 2010; 27(7):640-56. PubMed ID: 20681746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
